Reaching Patients Where They Are: Experience With LAI Antipsychotics in Community Practice

In this episode, Dr Robert Cotes and Dr David Goldsmith discuss their clinical experience with long-acting injectable antipsychotic treatments in the Grady Health System, with a focus on communication strategies to educate patients on their treatment options and engage them in shared decision-making.

Presenters: 

Robert O. Cotes, MD, DFAPAAssociate Professor and Distinguished PhysicianDirector, Clinical & Research Program for Psychosis at Grady Health SystemDirector, Project ARROW at Grady Health SystemDepartment of Psychiatry and Behavioral SciencesEmory University School of MedicineAtlanta, Georgia

David R. Goldsmith, MD, MScAssociate ProfessorDirector, Inflammation, Motivation, and Negative Symptoms of Schizophrenia (InMotioNSS) LabCo-Director, Clinical & Research Program for Psychosis at Grady Health SystemDirector, PSTAR Clinic at Grady Memorial HospitalFaculty, Emory Behavioral Immunology ProgramCo-Director, Psychiatry Residency Research TrackDepartment of Psychiatry and Behavioral SciencesEmory University School of MedicineAtlanta, Georgia

This content is part of an online CME program supported by educational grants from Indivior Inc.; Otsuka America Pharmaceutical, Inc. and Lundbeck; and Teva Pharmaceuticals. 

Link to full program: https://bit.ly/414XkY4